OH HB588 | 2023-2024 | 135th General Assembly

Status

Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on May 15 2024 - 25% progression
Action: 2024-05-21 - Referred to committee: Public Health Policy
Pending: House Public Health Policy Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To enact section 4729.521 of the Revised Code to prohibit drug manufacturers and wholesalers from taking certain actions regarding reimbursements made to 340B covered entities.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Regards drug reimbursements made to 340B covered entities

Sponsors


History

DateChamberAction
2024-05-21HouseReferred to committee: Public Health Policy
2024-05-15HouseIntroduced

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
4729521New CodeSee Bill Text

Ohio State Sources


Bill Comments

feedback